Abe M, Yokoyama H, Tohmiya Y, Okitsu Y, Ohguchi H, Kohata K, Yamamoto J, Onishi Y, Ishizawa K, Kameoka J, Harigae H.
Plasma cell leukemia maintaining complete remission by syngeneic stem cell transplantation combined with low-dose thalidomide maintenance therapy.
Intern Med. 2009;48(20):1833-5.
Hirabayashi Y, Ishii T, Harigae H.
Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice.
Rheumatol Int. 2010 Jun;30(8):1041-8. doi: 10.1007/s00296-009-1095-0.
Ichikawa S, Kohata K, Okitsu Y, Suzuki M, Nakajima S, Yamada MF, Onishi Y, Yamamoto J, Suzuki S, Ishizawa K, Kameoka J, Harigae H.
Acquired hemophilia A with sigmoid colon cancer: successful treatment with rituximab followed by sigmoidectomy.
Int J Hematol. 2009 Jul;90(1):33-6. doi: 10.1007/s12185-009-0347-9.
Ishizawa K, Ogura M, Hamaguchi M, Hotta T, Ohnishi K, Sasaki T, Sakamaki H, Yokoyama H, Harigae H, Morishima Y.
Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study.
Cancer Sci. 2009 Feb;100(2):357-62. doi: 10.1111/j.1349-7006.2008.01047.x.
Ohguchi H, Sugawara T, Harigae H.
Thrombotic thrombocytopenic purpura complicated with hypereosinophilic syndrome.
Intern Med. 2009;48(18):1687-90.
Ohguchi H, Sugawara T, Ishikawa I, Okuda M, Tomiya Y, Yamamoto J, Onishi Y, Fujiwara Yamada M, Ishizawa K, Kameoka J, Harigae H.
A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma: beta2-microglobulin associated with time to progression.
Int J Hematol. 2009 Apr;89(3):342-7. doi: 10.1007/s12185-009-0279-4.
Shirai T, Takahashi R, Tajima Y, Kohata K, Yamamoto J, Fujii H, Takasawa N, Ishizawa K, Ichinohasama R, Ishii T, Harigae H.
Peripheral T cell lymphoma with a high titer of proteinase-3-antineutrophil cytoplasmic antibodies that resembled Wegener's granulomatosis.
Intern Med. 2009;48(23):2041-5.
Yamada MF, Miyamura K, Fujiwara T, Kohata K, Okitsu Y, Ohguchi H, Yamamoto J, Yokoyama H, Tomiya Y, Ishizawa K, Kameoka J, Harigae H.
Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.
Transplant Proc. 2008 Dec;40(10):3637-42. doi: 10.1016/j.transproceed.2008.06.102.
Yokoyama H, Harigae H.
[Management of anemia and bone marrow hypoplasia in the treatment of myeloid leukemia].
Nihon Rinsho. 2009 Oct;67(10):1974-7. Review. Japanese.
Iseki Y, Imoto A, Okazaki T, Harigae H, Takahashi S.
Identification of annexin 1 as a PU.1 target gene in leukemia cells.
Leuk Res. 2009 Dec;33(12):1658-63. doi: 10.1016/j.leukres.2009.04.010.
Okuyama R, Shimada R, Kameoka J, Harigae H, Aiba S.
Occurrence of poroid hidradenomas after haematopoietic stem cell transplantation.
J Eur Acad Dermatol Venereol. 2009 Sep;23(9):1109-11. doi: 10.1111/j.1468-3083.2009.03110.x.
Tobinai K, Watanabe T, Ogura M, Morishima Y, Hotta T, Ishizawa K, Itoh K, Okamoto S, Taniwaki M, Tsukamoto N, Okumura H, Terauchi T, Nawano S, Matsusako M, Matsuno Y, Nakamura S, Mori S, Ohashi Y, Hayashi M, Endo K.
Japanese phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma.
Cancer Sci. 2009 Jan;100(1):158-64. doi: 10.1111/j.1349-7006.2008.00999.x.
Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, Wasada I, Kinoshita T, Ohshima K, Matsuno Y, Terauchi T, Nawano S, Ishikura S, Kagami Y, Hotta T, Oshimi K.
Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
J Clin Oncol. 2009 Nov 20;27(33):5594-600. doi: 10.1200/JCO.2009.23.8295.